(Q41198126)
Statements
Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess (English)
V R Obeyesekere
K Li
R C Wilson
M I New
J W Funder